The Nucleate Netherlands Ecosystem Showcase is our annual event that brings together trainees, innovators, entrepreneurs, investors and stakeholders from the Dutch life sciences sector.
This year’s event focuses on how biotech companies can translate cutting-edge research into resilient, scalable businesses that have lasting impact in the real world. Expect inspiring keynotes, panel discussions on the bio-innovation landscape, pitches from startups, including Global Virtual Activator participants (Gateway Bio and EightSix Science), and, of course, plenty of opportunity for networking.
In addition, you can expect a pitch from startup Glyco Diagnostics and our Stéfan Ellenbroek will participate in Panel 1: From lab to market.
Sign up now to mark the date in your calendar and be notified of speakers and the full program as soon as they are announced.
Programme:
- 13:30 – Reception and registration
- 14:00 – Welcome speech
- 14:20 – Keynote
- 14:40 – Panel 1: From lab to market: implementation, regulation and scale-up in the Dutch ecosystem
- 15:10 – Coffee break
- 15:40 – Startup pitches
- 16:20 – Panel 2: Reality check funding 2026: what will actually get funding
- 16:50 – Closing remarks
- 17:00 – Networking
- 18:30 – End
Keynote Speaker
Jan van de Winkel is CEO of Genmab.
- The first panel discusses the operational and regulatory realities of turning discoveries into viable products.
- The second panel explores how early-stage biotech startups can realistically and competitively position themselves in the current investment climate.
About the organizer
Nucleate is a 501(c)(3) nonprofit organization dedicated to supporting the next generation of biotech leaders. With chapters in 41 regions and participation from more than 280 academic institutions, Nucleate fosters new knowledge communities and connects emerging talent to a global biotech network.
Through open-access educational programs, Nucleate helps make biotech innovation more accessible by lowering barriers and helping founders focus on developing breakthrough technologies.
